Planning Capital Management Corp Neogenomics Inc Transaction History
Planning Capital Management Corp
- $151 Billion
- Q3 2024
A detailed history of Planning Capital Management Corp transactions in Neogenomics Inc stock. As of the latest transaction made, Planning Capital Management Corp holds 1,156 shares of NEO stock, worth $14,345. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,156
Previous 1,156
-0.0%
Holding current value
$14,345
Previous $16 Million
6.34%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding NEO
# of Institutions
282Shares Held
124MCall Options Held
751KPut Options Held
107K-
Black Rock Inc. New York, NY19.7MShares$244 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$177 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.53MShares$81 Million0.07% of portfolio
-
Janus Henderson Group PLC London, X06.17MShares$76.5 Million0.05% of portfolio
-
Brown Advisory Inc6.16MShares$76.4 Million0.13% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.56B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...